🔗 Share this article

This year's prestigious award in Physiology or Medicine has been granted for revolutionary findings that illuminate how the body's defense network attacks dangerous infections while sparing the body's own cells.

A trio of esteemed scientists—Japan's Prof. Sakaguchi and American scientists Mary Brunkow and Dr. Ramsdell—share this honor.

Their work uncovered unique "security guards" within the immune system that remove malfunctioning defense cells capable of attacking the body.

The findings are now enabling innovative treatments for autoimmune diseases and malignancies.

The laureates will divide a prize fund valued at 11 million Swedish kronor.

Crucial Findings

"The research has been essential for comprehending how the immune system operates and the reason we don't all develop serious self-attack conditions," commented the head of the award panel.

This team's research explain a fundamental question: In what way does the defense system protect us from numerous invaders while leaving our own tissues intact?

The immune system uses immune cells that search for indicators of infection, even pathogens and germs it has not met before.

These cells utilize sensors—called recognition units—that are generated by chance in a vast number of variations.

This gives the defense network the capacity to combat a wide array of invaders, but the randomness of the process unavoidably creates immune cells that can target the host.

Security Guards of the Body

Researchers previously understood that a portion of these problematic defense cells were eliminated in the immune organ—the site where white blood cells develop.

This year's award honors the discovery of regulatory T-cells—known as the body's "security guards"—which patrol the body to neutralize any immune cells that assault the healthy cells.

We know that this mechanism fails in self-attack conditions such as type-1 diabetes, MS, and RA.

A prize committee stated, "These findings have established a novel area of investigation and accelerated the development of new treatments, for instance for cancer and immune disorders."

Regarding cancer, regulatory T-cells prevent the system from attacking the growth, so research are focused on reducing their quantity.

For autoimmune diseases, trials are testing boosting T-reg cells so the body is no longer being harmed. A comparable method could also be useful in minimizing the risks of transplanted organ rejection.

Pioneering Studies

Prof Shimon Sakaguchi, from Osaka University, conducted tests on rodents that had their thymus extracted, causing self-attack conditions.

The researcher demonstrated that introducing defense cells from other animals could stop the illness—implying there was a system for preventing defenders from harming the host.

Dr. Brunkow, affiliated with the a research center in Seattle, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in a California city, were investigating an inherited immune disorder in rodents and people that resulted in the identification of a genetic factor critical for how T-regs function.

"Their pioneering work has uncovered how the body's defenses is controlled by regulatory T cells, stopping it from accidentally targeting the body's own tissues," commented a leading physiology specialist.

"The research is a remarkable illustration of how basic biological study can have far-reaching implications for public health."